Fulco CA, Liverman CT, Sox HC (eds). Gulf War and Health. Volume 1. Depleted Uranium, Sarin, Pyridostigmine Bromide, Vaccines. Institute of Medicine, National Academy Press, Washington, DC, 2000.



Abou-Donia MB, Wilmarth KR Jensen KJ, Oehme FW, Kurt TL. Neurotoxicity resulting from co-exposure to pyridostigmine bromide, DEET and Permethrin: Implications of Gulf War chemical exposures. J Toxicol Environ Health 1996a; 48:35-56.

Abou-Donia MB, Wilmarth KR, Abdel-Rahman A, Jensen KJ, Oehme FW, Kurt TL. Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos. Fundam Appl Toxicol 1996b; 34:201-22.

Asa PB, Cao Y and Garry RF. Antibodies to squalene in Gulf War syndrome. Exp Mol Pathol 2000; 68:55-64.

Anthrax Vaccine Immunization Program (AVIP). Vaccine, Dosing Schedule. 1999.

Barsky AJ, Borus JF. Functional Somatic Syndromes. Ann Intern Med 1999; 130:910-921.

Bioport Corporation. Vaccine, Package Insert. 1999.

Brachman PS, Gold H, Plotkin S, Fekety FR, Werrin M, Ingraham NR. Field evaluation of a human anthrax vaccine. Am J Public Health 1962; 52:632-645.

Canadian Board of Inquiry, Final Report: Croatia. 26 January 2000.

Canadian Department of National Defence, Health Study of Canadian Forces Personnel Involved in the 1991 Conflict in the Persian Gulf, 20 April 1998.

Centers for Disease Control and Prevention. Unexplained illness among Persian Gulf War veterans in an Air National Guard unit: Preliminary report --August 1990-March 1995. MMWR 44(23):443-447.

Conway DN, DeFraites RF, Gray GC, Goldenbaum MB, Wishik SM. The risk of birth defects among children of the Persian Gulf War Veterans. N Engl J Med 1997; 336:1650-1656.

Cowan DN, Lange J. Asthma cases in Army servicemembers participating in the Comprehensive Clinical Evaluation Program (CCEP). Conference on Federally Sponsored Gulf War Veterans� Illnesses Research, Pentagon City, Arlington, VA, 1998.

Demicheli V, Rivetti D, Deeks JJ, Jefferson T, and Pratt M. The effectiveness and safety of vaccines against human anthrax: a systematic review. Vaccine 1998 16:880-884.

Dlugosz LJ, Hocter WJ, Kaiser KS, Knoke JD, Heller JM, Hamid NA, Reed RJ, Kendler KS, Gray GC. Risk factors for mental disorder hospitalization after Persian Gulf War: U.S. Armed Forces, June 1, 1991-September 30, 1993. J Clin Epidemiol 1999; 52(12):1267-1278.

Doebbeling BN, Clarke WR, Watson D, et al. Is there a Persian Gulf War Syndrome? Evidence from a large population-based survey of veterans and nondeployed controls. Am J Med 2000; 108: 695-704.

Drake-Baumann R, Seil FJ. Effects of exposure to low-dose pyridostgmine on neuromuscular junctions in vitro. Muscle & Nerve 1999; 22:696-703.

Draxler RR, McQueen JT, Stunder BJB. An evaluation of air pollution exposures due to the 1991 Kuwait oil fires using a Lagrangian model. Atmospheric Environment 1994; 28 (13): 2197-2210.

Etzel RA and Ashley DL. Volitile organic compounds in the blood of persons in Kuwait during the oil fires. Int Arch Occup Environ Health 1994; 66(2):125-129.

Evans L. VA data shows increased percentage of undiagnosed illness and total disability among certain groups of veterans who served in Southwest Asia between August 2, 1990 and July 31, 1991. Democratic staff follow up report. Committee on Veterans Affairs, U.S. House of Representatives, 1999 October 25.

Frost SD. Gulf War syndrome: Proposed causes. Cleveland Clinic Journal of Medicine. 2000; 67:17-20.

Fukuda K, Nisenbaum R, Stewart G, et. al. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA 1998; 280(11):981-988.

Fulco CA, Liverman CT, Sox HC (eds). 2000. Gulf War and Health. Volume 1. Depleted Uranium, Sarin, Pyridostigmine Bromide, Vaccines. Institute of Medicine, National Academy Press, Washington, DC, 2000.

Golomb BA. A review of Scientific Literature As It Pertains to Gulf War Illness (Volume 2): Pyridostigmine Bromide. RAND, National Defense Research Institute, Santa Monica, CA, 1999.

Gray GC, Coate BD, Anderson CM, Kang HK, Berg SW, Wigmal FS, Knoke JD, Barret-Connor E. The post-war hospitalization experience of U.S. veterans of the Persian Gulf War. N Engl J Med 1996; 335:1505-1513.

Gray GC, Smith TC, Knoke JD, and Heller JM. The postwar hospitalization experience of Gulf War Veterans Possibly Exposed to Chemical Munitions Destruction At Khamisiyah, Iraq. Am J Epidemiol 1999a; 150(5):532-540.

Gray GC, Smith TC, Kang HK, Knoke JD. Are Gulf War veterans suffering War-related illnesses? Federal and civilian hospitalizations examined, June 1991 to December 1994. Am J Epidemiol 2000; 151: 63-71.

Gray GC, Kaiser KS, Hawksworth AW, Hall FW, and Barrett-Connor E. Increased postwar symptoms and psychological morbidity among U.S. Navy Gulf War veterans. Am J Trop Med Hyg 1999b; 60(5): 758-766.

Gray GC, Kaiser KS, Hawksworth AW, and Watson HL. No Serologic Evidence of an association found between gulf war service and Mycoplasma fermentans infection. Am J Trop Med Hyg 1999c; 60(5): 752-7.

Helmkamp JC. United states military casualty comparisons during the Persian Gulf War. J Occup Med 1994; 36(6): 609-615.

Haley RW, Kurt TL, Horn J. Is there a Gulf War Syndrome? JAMA 1997; 277:215-222.

Haley RW, Horn J, Roland PS, et al. Evaluation of neurologic function in Gulf War veterans. JAMA 1997; 277:223-230.

Haley RW, Kurt TL. Self-reported exposure to neurotoxic chemical combinations in the Gulf War. JAMA 1997; 277(3):231-237.

Haley RW, Billecke S, and La Du BN. Association of low PON1 Type Q (Type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol Appl Pharmacol 1999; 157:227-233.

Haley RW, Marshall WW, McDonald GG, Daughtery MA, Petty F, and Fleckenstein JL. Brain abnormalities in Gulf War Syndrome: evaluation with 1H MR spectroscopy. Neuroradiology 2000; 215(3):807-817.

Hegele RA. Paraoxonase genes and disease. Ann Med 1999; 31:217-224.

Hernandez LM, Durch JS, Blazer DG II, Hoverman IV (eds). Gulf War Veterans: Measuring Health. Institute of Medicine, National Academy Press, Washington, DC, 1999.

Hooper FJ, Squibb KS, Seigel EL, McPhaul K, Keogh JP. Elevated urine excretion by soldiers with retained uranium shrapnel. Health Physics Society 1999; 7(5):512-519.

Horn J, Haley RW, Kurt TL. Neuropsychological correlates of Gulf War Syndrome. Arch Clin Neuropsych 1997;12:531-544.

Hotopf M, David A, Hull L, Ismail K, Unwin C, Wessely S. Role of vaccinations as risk factors for ill health in veterans of the Gulf War: cross sectional study. British Med J 20 May 2000, 320:1363-1367.

Hyams KC, Hanson K, Wingnall FS, Escamill J, Oldfield EC. The impact of infectious diseases on health of US troops deployed to the Persian Gulf during Operations Desert Storm and Desert Shield. Clin Infect Dis 1995; 20:1497-1504.

Iowa Study Group. Self-reported illness and health status among Gulf War veterans. JAMA 1997; 277: 238-245.

Ireland C. Conference studies fatigue. Experts here for three-day meeting on root of illnesses. Rochester News, Democrat and Chronicle (NY). 2000 August 18.

Ismial K, Everitt B, Blatchley N, et. al. Is there a Gulf War syndrome? Lancet 1999; 353(9148):179-182.

Joseph SC, and the Comprehensive Clinical Evaluation Program Evaluation Team. A Comprehensive Clinical Evaluation of 20,000 Persian Gulf War Veterans. Mil Med 1997; 162:149-55.

Kaiser KS, Hawksworth QW, Gray GC. Pyridostigmine Bromide intake during the Persian Gulf War is not associated with postwar handgrip strength. Mil Med 2000; 165:165-168.

Kang HK, Bullman TA. Mortality among U.S. veterans of the Persian Gulf War. New Engl J Med 1996; 335:1498-1504.

Kang HK, Mahan CM, Lee KY et al. Illnesses among United States veterans of the Gulf War: a population-based survey of 30,000 veterans. J Occup Environ Med 2000; 42: 1-11.

Kang HK. National health survey of Persian Gulf veterans, Department of Veterans Affairs, project VA-2, ongoing. As cited in: Department of Veterans Affairs. Annual Report to Congress, Federally sponsored research on Gulf War veterans' illness for 1998. June 1999.

Klenke WJ. DOD, OTSG NBC. Memo for the record: Drug and vaccine usage during Operation Desert Shield/Storm; 1991 December 9.

Knoke JD, Smith TC, Gray GC, et al. Factor analysis of self-reported symptoms: does it identify a Gulf War syndrome? Am J Epidemiol 2000; 152 (4): 1-10.

Korényi-Both AL, László Svéd MG, Korényi-Both GE, Juncer DJ, Korényi-Both AL, Székely A. The role of the sand in chemical warfare agent exposure among Persian Gulf War veterans: Al Eskan disease and "dirty dust" Mil Med 2000; 165:321-336.

Korényi-Both AL, Korényi-Both AL, Juncer DJ. Al Eskan Disease: Persian Gulf syndrome. Mil Med 1997; 162:1-13.

Korényi-Both AL, Korényi-Both AL, Molinár AC, Fidelus-Gort R. Al Eskan Disease: Desert Storm pneumonitis. Mil Med 1992; 157:452-462.

Kroenke K, Koslewe P, and Roy M. Symptoms in 18,495 Persian Gulf War Veterans. J Occup Environ Med 1998; 40:520-528.

Kroenke K, Price RK, Symptoms in the Community: Prevalence, Classification, and Psychiatric Comorbidity, Arch Int Med, Nov 8, 1993; 153:2474-2480.

Longnecker MP and Michalek JE. Serum dioxin level in relation to diabetes mellitus among Air Force veterans with background levels of exposure. Epidemiology 2000; 11(1):44-48.

Lotti M. Causes of the Gulf War syndrome: testing hypothesis. Muscle Nerve 1999; 22:663-665.

Magill AJ, Grogl M, Gasser RA, Sun W, Oster CN. Visceral infection caused by Leishmania tropica in veterans of Operation Dessert Storm. New Engl J Med 1993; 328:1383-1387.

Marshall GN, Davis LM, Sherbourne CD, A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Volume 4, Stress; RAND, National Defense Research Institute, 2000.

McCauley LA, Joos SK, Spencer PS, Lasarev M, Shuell T, and Members of the Portland Environmental hazards Research Center. Strategies to assess validity of self-reported exposures during the Persian Gulf War. Environ Res Sec. A, 1999; 81:195-205.

McDiarmid MA, Hooper FJ, Squibb K, McPhaul K. The utility of spot collection for urinary uranium determinations in depeleted uranium exposed gulf war veterans. Health Physics Society 1999; 77(3): 261-264.

McDiarmid MA, Keogh JP, Hooper FJ, McPhaul K, Squibb K, Kane R, DiPino R, Kabat M, Kaup B, Anderson L, Hoover D, Brown L, Hamilton M, Jacobson-Fram D, Burrows and Walsh M. Health effects of depleted uranium on exposed gulf war veterans. Environ Res Sec A 2000; 82:168-180.

McDonnell JA. After Desert Storm, The U.S. Army and the Reconstruction of Kuwait. Department of the Army, Washington D.C., 1999.

Michalek JE Akhtar FZ and Kiel JL. Serum Dioxin, Inulin, Fasting Glucose, and Sex Hormone-binding Globulin in Veterans of Operations Ranch Hand. J Clin Endocrinol Metab 1999; 84:1540-3.

Miller AC, Fuciarelli AF, Jackson WE, Ejnik EJ, Emond C, Strocko S, Hogan J, Page N and Pellmar T. Urinary and cerum mutagenicity studies with rats implanted with depleted uranium or tantalum pellets. Mutagenesis 1998; 13(6):643-648.

Moore DH. Health effects of exposure to low dose of nerve agent a review of present knowledge. Drug and Chemical Toxicology 1998; 21 (Suppl. 1), 123-130.

Murphy FM, Kang H, Dalager NA, The health status of Gulf War veterans: lessons learned from the Department of Veterans Affairs Health Registry. Mil Med 1999; 164(5):327-331.

Murphy F, Browne D, Mather S, et. al. Women in the Persian Gulf War: health care implications for active duty troops and veterans. Mil Med 1997; 162(10):656-660.

Nasralla M, Haier J, and Nicolson GL. Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome and/or fibromyalgia syndrome. Eur J Clin Microbiol Infect Dis 1999; 18:859-865

National Center for PTSD. Fact sheet, What is PTSD?, last update June 12, 2000;

National Institutes of Health. Consensus Statements. NIH Consensus Development Program. The Persian Gulf Experience and Health (#14). Technology Assessment Workshop Statement. 1994 April 27-29; 1-12

Nicholson GL, Rosenberg-Nicolson NL. Doxycycline treatment and Desert Storm. JAMA 1995 273(8):618-619.

Nicolson GL, Hyman E, Korenyi-Both A, et al. Progress on Persian Gulf War illnesses--reality and hypotheses. International Journal of Occupational Medicine and Toxicology 1995; 4: 365-370.

Nisenbaum R, Barrett D, Reyes M and Reeves W. Deployment stressors and a chronic multisymptom illness among Gulf War veterans. J Nerv Ment Dis. 2000; 188(5):259-266.

Nobel D. Back into the storm: reanalyzing health effects of the Gulf War, Analyt Chem 1999; 66:805A-808A.

Office of the Surgeon General Department of the Army, United States of America. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. The Office of the Surgeon General. TMM Publications, Washington D.C.

Oldfield EC, Wallace MR, Hyams KC, Yousif AA, Lewis DE, Bourgeois AL. Endemic Infectious disease of the Middle East. Rev Infect Dis 1991; 13:s199-s217.

Peacock MD, Morris MJ, Houghland MA, Anders GT, and Blanton. Sleep apnea syndrome in a sample of veterans of the Persian Gulf War. Mil Med 1997; 162:249-251.

Pellmar TC, Fuciarelli AF, Ejnik JW, Hamilton M, Hogan J, Strocko S, Emond C, Mottaz HM and Landaur MR. Distribution of uranium in rats implanted with depleted uranium pellets. Toxicological Sciences 1999;49:29-39.

Pepper LD, Stinson MS, Heaton KJ. Pulmonary function evaluations in Army servicemembers who returned to the US from the Persian Gulf through Ft. Devens. Conference on Federally Sponsored Gulf War Veterans� Illnesses Research, Pentagon City, Arlington, VA 1999.

Poirier MC, Weston A, Schoket B, Shamkhani H, Pan CF, McDoarmid MA, Scott BG, Deeter DP, Heller JM, Jacobson-Kram D and Rothman N. Biomonitoring of United States Army soldier in Kuwait in 1991. Cancer Epidemiol Biomarkers Prev 1998; 7(6):545-551.

Proctor SP, Heeren T, White RF, Wolfe J, Borgos MS, Davis JD, Pepper L, Clapp R, Sutker PB, Vasterling JJ and Ozonoff D. Health Status or Persian Gulf War Veterans: self-reported symptoms, environmental exposures and the effect of stress. Int J Epidemiol. 1998; 27(6): 1000-1010

Proctor SP, White RF, Wolfe J. Self-reported respiratory disease from two cohorts of deployed servicemembers (one from Ft. Devens and one from the New Orleans area). Conference on Federally Sponsored Gulf War Veterans� Illnesses Research, Pentagon City, Arlington, VA 1999.

Proctor SP, Stinson MC, Heaton KJ, Pepper L, Ozonoff D. Reported oil fire smoke exposure compared to modeled estimates in Gulf War veterans. Conference on Federally Sponsored Gulf War Veterans� Illnesses Research, Pentagon City, Arlington, VA 1999.

Rhem KT. Gulf War Illness Officials Plan Meeting Briefs. American Forces Press Service, April 5, 2000;

Samet JM, Morgan MV, Key CR, et al. Studies of uranium miners in New Mexico. Ann Am Conf Gov Ind Hyg 1986; 15:351-355.

Sartin, JS. Gulf War Illnesses: Causes and Controversies, Mayo Clin Proc 2000; 75:811-819.

Sato PA, Ryan M, Gray GC, Hoffman KJ, et al. Surveillance for Adverse Events Associated with Anthrax Vaccination - U.S. Department of Defense, 1998-2000. MMWR 2000; 49(16):341-344

Shlyakhov EN, Rubinstein E. Human Live anthrax vaccine in the former USSR. Vaccine 1994; 12:727-730.

Spektor DM. A review of the scientific literature as it pertains to Gulf War illnesses, Volume 6, Oil Well Fires. RAND, National Defense Research Institute, Santa Monica, CA, 1998.

United Nations Special Commission (UNSCOM). Note by the Secretary-General. S/1998/1106 1998.

United Nations Special Commission (UNSCOM). UNSCOM: Chronology of Main Events. 1999.

United Nations Special Commission (UNSCOM). Note by the Secretary-General. Distr. General S/25977 June 21, 1993.

United Nations Special Commission (UNSCOM). NOTE DU SECRÉTAIRE GÉNÉRAL S/1998/920 6 October 1998.

U.S. Army Environmental Hygiene Agency, Final report, Kuwaiti oil fire health risk assessment, No. 39-26-L192-91, 5 May - 3 December 1991. 18 February 1994.

U.S. Army Center for Health Promotion and Preventive Medicine, Environmental surveillance health risk assessment No. 47-EM-7121-98, Kuwait oil fires, 1 October 1997 - 15 April 1998. 29 June 1998.

U.S. Department of Defense, Defense Science Board, Office of the Under Secretary of Defense for Acquisition and Technology, "Report of the Defense Science Board Task Force on Persian Gulf War Health Effects," June 1994.

U.S. Department of Defense. Comprehensive Clinical Evaluation Program for Persian Gulf War Veterans. CCEP report on 18598 participants. 1996 April 2.

U.S. Department of Health and Human Services. Toxicological profile for uranium. Agency for Toxic Substances and Disease Registry (ATSDR), Atlanta, GA, 2000.

U. S. Environmental Protection Agency (Office of transportation and air quality). Proposed heavy-duty engine and vehicle standards and highway diesel fuel sulfur control requirements. Air and Radiation Regulatory Announcement 2000; EPA420-F-00-022.

U.S. Department of Veterans Affairs (VA). Annual report to Congress, federally sponsored research on Gulf War veterans� illnesses for 1998. Appendices. June 1999.

U.S. Department of Veterans Affairs (VA). VA Fact Sheet. VA Programs for Gulf War Veterans. April 1998.

Unwin C, Blatchley N, Coker W, et. al. Health of UK servicemen who served in Persian Gulf War. Lancet 1999; 353(9148):169-178.

Wagner AW, Wolfe J, Rotnitsky A, et al. An investigation of the impact of posttraumatic stress disorder on physical health. J Traumatic Stress 2000; 13:41-55.

Waxweiler RJ, Archer VE, Roscoe RJ, et al. Mortality patterns among a retrospective cohort of uranium mill workers. Proceedings of the Health Physics Society 1983; 428-435.

Wolfe J, Erickson DJ, Sharkansky EJ, et al. Course and predictors of posttraumatic stress disorder among Gulf War veterans: a prospective analysis. J Consulting and Clin Psych 1999; 67 (4): 520-528.

Wolfe J, Proctor SP, Erickson DJ, Heerer T, Friedman MJ, Huang MT, Sutker PB, Vasterling JJ, and White RF. Relationship of psychiatric status of Gulf War veterans' health problems. Psychosomatic Medicine 1999; 61:532-540.

Writer JV, Defraites RF, Brundage JF. Comparative Mortality among U.S. Military Personnel in the Persian Gulf Region and Worldwide During Operations Dessert Shield and Dessert Storm. JAMA 1996; 275:118-121.



Hall DP, Cipriano ED, Bicknell G. Preventive Mental Health Interventions in Peacekeeping Missions to Somalia and Haiti. Mil Med 1997; 163:41-43.

Brown D. Gulf War Mystery Remains. Medical Experts Fail to Finger Specific cause of Syndrome. The Washington Post, September 8, 2000, pA31.

Center for Strategic & International Studies. "American Military Culture in the Twenty-First Century", Executive Summary. Center for Strategic & International Studies, Washington, DC, 2000.

Deahl M, et al. Preventing Psychological Trauma In Soldiers: The Role of Operational Stress Training And Psychological Debriefing. Br J Med Psychol 2000; 73:77-85.

Evans M. Training Can Help Troops To Combat Stress, London Times, March 8, 2000.

Fulco CE, Liverman CT, and Sox HC. Gulf War and Health. Volume 1. Depleted Uranium, Sarin, Pyridostigmine Bromide, Vaccines. Institute of Medicine, National Academy Press, Washington, DC, 2000.

Hyams KC, Wignall FS, Roswell R. War syndromes and their evaluation: from the U.S. civil War to the Persian Gulf War. Ann Intern Med 1996; 125:398-405.

Marshall GN, Davis LM, Sherbourne CD. A Review of the Scientific Literature As It Pertains to Gulf War Illnesses. Volume 4, Stress, National Defense Research Institute, RAND, Santa Monica, CA. 2000

Marlowe DH. Psychological and Psychosocial Consequences of Combat and Deployment with Special Emphasis on the Gulf War. RAND, National Defense Research Institute, Santa Monica, CA (draft report; publication expected 2000).

Niesenbaum et al; Deployment Stressors and a Chronic Multisymptom Illness among Gulf War Veterans. J Nerv Ment Dis 2000. 188:259-265.

Presidential Advisory Committee On Gulf War Veterans� Illnesses Final Report, Washington, DC: U.S. Government Printing Office, December 1996.

Presidential Advisory Committee On Gulf War Veterans� Illnesses Special Report, Washington, DC: U.S. Government Printing Office, October 1997.

U.S. Army Field Manual "Leaders Manual for Combat Stress Control"; FM 22-51. Headquarters, Department of the Army, Washington, DC. September 1994.; US Army Field Manual "Combat Stress Control in a Theater of Operations"; FM 8-51. Headquarters, Department of the Army, Washington, DC. September 1994.

U.S. Army, Leadership, Individual Subcourse 7038 (IS7038), Lesson Five, Minimize Combat Stress, Army Institute for Professional Development, U.S. Army.

U.S. Department of Defense Directive 6490.5, Combat Stress Control (CSC) Programs, February 1999.